These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 33319423

  • 21. Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis.
    Berkow EL, Manigaba K, Parker JE, Barker KS, Kelly SL, Rogers PD.
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5942-50. PubMed ID: 26169412
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Fluconazole and Voriconazole Resistance in Candida parapsilosis Is Conferred by Gain-of-Function Mutations in MRR1 Transcription Factor Gene.
    Branco J, Silva AP, Silva RM, Silva-Dias A, Pina-Vaz C, Butler G, Rodrigues AG, Miranda IM.
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6629-33. PubMed ID: 26248365
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Research of Mrr1, Cap1 and MDR1 in Candida albicans resistant to azole medications.
    Feng W, Yang J, Yang L, Li Q, Zhu X, Xi Z, Qiao Z, Cen W.
    Exp Ther Med; 2018 Feb; 15(2):1217-1224. PubMed ID: 29434708
    [Abstract] [Full Text] [Related]

  • 26. Competitive Fitness of Fluconazole-Resistant Clinical Candida albicans Strains.
    Popp C, Hampe IAI, Hertlein T, Ohlsen K, Rogers PD, Morschhäuser J.
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461316
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A Hyperactive Form of the Zinc Cluster Transcription Factor Stb5 Causes YOR1 Overexpression and Beauvericin Resistance in Candida albicans.
    Ramírez-Zavala B, Manz H, Englert F, Rogers PD, Morschhäuser J.
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249688
    [Abstract] [Full Text] [Related]

  • 37. A CTG Clade Candida Yeast Genetically Engineered for the Genotype-Phenotype Characterization of Azole Antifungal Resistance in Human-Pathogenic Yeasts.
    Accoceberry I, Rougeron A, Biteau N, Chevrel P, Fitton-Ouhabi V, Noël T.
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038279
    [Abstract] [Full Text] [Related]

  • 38. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.
    Jin L, Cao Z, Wang Q, Wang Y, Wang X, Chen H, Wang H.
    BMC Infect Dis; 2018 Apr 10; 18(1):162. PubMed ID: 29631565
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.